Diclofenac Sodium Gel
Loading...Diclofenac Sodium Gel Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
As with other NSAIDs, anaphylactoid reactions may occur in patients without prior exposure to diclofenac. Diclofenac sodium should be given with caution to patients with the aspirin triad. The triad typically occurs in asthmatic patients who experience rhinitis with or without nasal polyps, or who exhibit severe, potentially fatal bronchospasm after taking aspirin or other NSAIDs.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Diclofenac Sodium Gel is indicated for the topical treatment of actinic keratoses (AK). Sun avoidance is indicated during therapy.
History
There is currently no drug history available for this drug.
Other Information
Diclofenac Sodium Gel, 3%, contains the active ingredient, diclofenac sodium, in a clear, transparent, colorless to slightly yellow gel base. Diclofenac sodium is a white to slightly yellow crystalline powder. It is freely soluble in methanol, soluble in ethanol, sparingly soluble in water, slightly soluble in acetone, and partially insoluble in ether. The chemical name for diclofenac sodium is:
Sodium [o-(2,6-dichloranilino) phenyl] acetate
Diclofenac sodium has a molecular weight of 318.13.
The CAS number is CAS-15307-79-6. The structural formula is represented below:
Diclofenac Sodium Gel also contains benzyl alcohol, hyaluronate sodium, polyethylene glycol monomethyl ether, and purified water.
1 g of Diclofenac Sodium Gel contains 30 mg of the active substance, diclofenac sodium.
Sources
Diclofenac Sodium Gel Manufacturers
-
E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
![Diclofenac Sodium Gel [E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Diclofenac Sodium Gel | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Diclofenac Sodium Gel is applied to lesion areas twice daily. It is to be smoothed onto the affected skin gently. The amount needed depends upon the size of the lesion site. Assure that enough Diclofenac Sodium Gel is applied to adequately cover each lesion. Normally 0.5 g of gel is used on each 5 cm x 5 cm lesion site. The recommended duration of therapy is from 60 days to 90 days. Complete healing of the lesion(s) or optimal therapeutic effect may not be evident for up to 30 days following cessation of therapy. Lesions that do not respond to therapy should be carefully re-evaluated and management reconsidered.
-
Global Pharmaceuticals, Division Of Impax Laboratories Inc.
Diclofenac Sodium Gel | Global Pharmaceuticals, Division Of Impax Laboratories Inc.
Diclofenac Sodium Gel, 3% is applied to lesion areas twice daily. It is to be smoothed onto the affected skin gently. The amount needed depends upon the size of the lesion site. Assure that enough Diclofenac Sodium Gel, 3% is applied to adequately cover each lesion. Normally 0.5 g of gel is used on each 5 cm x 5 cm lesion site. The recommended duration of therapy is from 60 days to 90 days. Complete healing of the lesion(s) or optimal therapeutic effect may not be evident for up to 30 days following cessation of therapy. Lesions that do not respond to therapy should be carefully re-evaluated and management reconsidered.
![Diclofenac Sodium Gel [Global Pharmaceuticals, Division Of Impax Laboratories Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8aadab37-9068-45a8-ac9a-8ad87d163b68&name=352da3e2-figure-01.jpg)
Login To Your Free Account